RLMD — Relmada Therapeutics Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Relmada Therapeutics Inc (RLMD), worth $10.28M combined. Over the quarter 1 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $9.28M | 0.03% | -5.2% |
| Persistent | $598.19K | 0.19% | +70.3% |
| Renaissance | $399.98K | 0.00% | -65.4% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.